Contraception in the COVID-19 pandemic: recommendations from the Korean society of contraception and reproductive health

Author: Jae Hoon LEE ¹ ; Jae Yen SONG ; Kyong Wook YI ; Jin Ju KIM ; Kyu Ri HWANG ; Jung-Ho SHIN ; Ji Young LEE ; Hee Dong CHAE
Author Information

1. Department of Obstetrics and Gynecology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
Publication Type:Review Article
From:Obstetrics & Gynecology Science 2022;65(2):125-132
CountryRepublic of Korea
Language:English
Abstract: Coronavirus disease 2019 (COVID-19) is associated with a systemic inflammatory response that activates coagulation in symptomatic patients. In addition, a rare form of thrombosis has been reported in people who received the COVID-19 vaccine, most of whom were women younger than 50 years of age. Considering that hormonal contraceptive methods widely used by women of childbearing age increase the risk of thrombosis, the development of guidelines for the use of hormonal contraceptives in the era of the COVID-19 pandemic is necessary. In this context, the Korean Society of Contraception and Reproductive Health provides guidelines for issues regarding contraception and reproductive health during the pandemic.